64Cu-NODAGA-LM3

N/A

Report date: 2025/11/20 16:04:40

NME

Base Information

Drug Name64Cu-NODAGA-LM3

Drug Alias Name64Cu-NODAGA-LM3

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 binders

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Hospital Basel

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Basel

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A